跳至主要内容
临床试验/CTRI/2024/04/065600
CTRI/2024/04/065600尚未招募4 期

A study comparing recovery characteristics of patients recieving either Sugammadex or Neostigmine and Glycopyrollate, for reversal of rocuronium induced Neuromuscular block - NI

Manipal Hospital0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • American Society of Anesthesiologists grades 1, 2, and 3 patients aged 18–60 years, coming for elective laparoscopic surgeries (lasting one to three hours) will be recruited for the study.

排除标准

  • 1. Patients with cardiorespiratory abnormalities (New York Heart Association heart failure grades 3 and 4.
  • 2. Known allergy to Rocuronium.
  • 3. Renal insufficiency (eGFR <60).
  • 4. Liver dysfunction (liver enzymes—serum glutamic oxaloacetic transaminase/ serum glutamic pyruvic transaminase values elevated by more than 50% of normal).
  • Underlying neuromuscular disease or the use of drugs known to interfere with neuromuscular transmission.
  • Intraoperative hypothermia (core temperature less than 35°C).
  • Known Emphysema.
  • Unwillingless to perform PFT.

研究者

相似试验